Previous Close | 0.0727 |
Open | 0.0749 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 0.0704 - 0.0809 |
52 Week Range | 0.0405 - 0.1395 |
Volume | |
Avg. Volume | 479,443 |
Market Cap | 27.169M |
Beta (5Y Monthly) | 2.12 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0090 |
Earnings Date | Jun 29, 2020 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for RDGL
Richland WA, May 12, 2022 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc is pleased to report that it expanded its intellectual property protection on several fronts. Our patent team filed our particle patent in more than ten patent offices that collectively cover 63 countries throughout the world. This year we also filed a provisional patent number 63-299,930 giving us broader protection on recent and projected developments on both our hydrogel and our particle components. This week we
Richland WA, April 21, 2022 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc is pleased to announce a combined IsoPet® therapy schedule into one treatment day, allowing for one production run to provide multiple Isopet® therapies that are done in any one of our current three regional clinics at Vista Veterinary Hospital in Washington, the University of Missouri and John Hopkins University in Maryland. As the number of patients increases additional days will be scheduled. This schedule str
Richland WA, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc is pleased to report that it filed its particle patent in several countries. Our new patent team filed the particle patent in the USA, Canada, the European Union, Japan, Australia, Brazil, China, India, South Korea, and the Russian Eurasian (Russia, Armenia, Azerbaijan, Belarus, Kazakhstan, Kyrgyzstan, Tajikistan, and Turkmenistan). Our patent counsel will also be pursuing amendments to increase the number of clai